Research and Development

Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …

Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …

Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …

British technology firm OwnFone has launched what it says is the first commercially available Braille phone. The device, which shares …

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …

Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …

Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …

K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division.  Williams …

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …